Skip to main content

Table 1 IgAN relapses following COVID-19 vaccination

From: IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report

Author

Age (Years)

Sex

Manufacture

Dose (1st/2nd)

Time between vaccine and onset (days)

Presentation

Pathology

Treatment

Response

Gul Rahim

52

F

Pfizer

2nd

 < 1

GH, AKI

N/A

None

Remission of GH in less than 1 week

Negrea

38

F

Pfizer

2nd

 < 1

GH, SRP

N/A

None

Remission of GH after 3 days

38

F

Pfizer

2nd

 < 1

GH

N/A

None

Remission of GH after 3 days

Perrin

22

M

Moderna

1st

2

GH

N/A

None

Remission of GH

41

F

Pfizer

1st

2

GH

N/A

None

Remission of GH

27

F

Pfizer

2nd

2

GH

N/A

None

Remission of GH

Plasse

N/A

N/A

Pfizer

2nd

5 to 6

GH, SRP, AKI

N/A

Corticosteroids

Remission of GH, AKI after 1 month, SRP within 2 months

N/A

N/A

Pfizer

2nd

1

GH

N/A

None

Remission of GH after 3 days

This Case

54

F

Moderna

2nd

2

GH, SRP, AKI

Active IgAN

Corticosteroids

Remission of GH after 2 days, AKI in 3 months

  1. Abbreviations: AKI Acute Kidney Injury, GH Gross Hematuria, SRP Subnephrotic Range Proteinuria